Hims & Hers Health
HIMS
$9.00
Share price
1.12%
Change (1 day)
116.87%
Change (1 year)
Revenue for Hims & Hers Health (HIMS)
Revenue in 2023 (TTM): $0.61 B
According to Hims & Hers Health's latest financial reports the company's current revenue (TTM) is $0.61 B. In 2022 the company made a revenue of $0.52 B an increase over the years 2021 revenue that were of $0.27 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Hims & Hers Health from 2020 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.61 B | 16.98% |
| 2022 | $0.52 B | 93.81% |
| 2021 | $0.27 B | 82.77% |
| 2020 | $0.14 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $1.7 M | -99.72% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $6.98 M | -98.87% | 🇬🇧 UK |
 Novavax NVAX | $1.91 B | 210.25% | 🇺🇸 USA |
 Novocure
NVCR | $0.52 B | -15.23% | Jersey |